Cargando…
Risk-Predictive and Diagnostic Biomarkers for Colorectal Cancer; a Systematic Review of Studies Using Pre-Diagnostic Blood Samples Collected in Prospective Cohorts and Screening Settings
SIMPLE SUMMARY: Currently, colorectal cancer screening typically involves stool tests, but a blood test might be more acceptable for screening participants. Most research on blood biomarkers for colorectal cancer has been conducted using samples from patients and may not be as predictive for early-s...
Autores principales: | Harlid, Sophia, Gunter, Marc J., Van Guelpen, Bethany |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430893/ https://www.ncbi.nlm.nih.gov/pubmed/34503217 http://dx.doi.org/10.3390/cancers13174406 |
Ejemplares similares
-
A two-tiered targeted proteomics approach to identify pre-diagnostic biomarkers of colorectal cancer risk
por: Harlid, Sophia, et al.
Publicado: (2021) -
The Metabolic Syndrome, Inflammation, and Colorectal Cancer Risk: An Evaluation of Large Panels of Plasma Protein Markers Using Repeated, Prediagnostic Samples
por: Harlid, Sophia, et al.
Publicado: (2017) -
Plasma ghrelin is probably not a useful biomarker for risk prediction or early detection of colorectal cancer
por: Sundkvist, Anneli, et al.
Publicado: (2019) -
Untargeted plasma metabolomics and risk of colorectal cancer—an analysis nested within a large-scale prospective cohort
por: Vidman, Linda, et al.
Publicado: (2023) -
Circulating levels of inflammatory markers and DNA methylation, an analysis of repeated samples from a population based cohort
por: Myte, Robin, et al.
Publicado: (2019)